Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.
about
Hypoxic control of metastasisAdvances in targeted therapies and new promising targets in esophageal cancerAXL kinase as a novel target for cancer therapyThe AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.The Gas6/TAM System and Multiple SclerosisThe Receptor Tyrosine Kinase AXL in Cancer ProgressionLigand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponsePrognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysisImplications of Hypoxia in Breast Cancer Metastasis to BoneCapture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signalingThe difficulty of targeting cancer stem cell nichesExpression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancerA rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.The CO-Regulation Database (CORD): a tool to identify coordinately expressed genesExploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics.Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancerClear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to FibrosisActivation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer.Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers.Breast cancer stem cells: Multiple capacities in tumor metastasis.Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processesAn engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.Efficient in vivo vascularization of tissue-engineering scaffoldsPromotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseDesign, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceThe Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaTWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.A systems view of epithelial-mesenchymal transition signaling states.CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genesAxl as a mediator of cellular growth and survivalAxl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion.Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating proteinPhosphoproteomic screen identifies potential therapeutic targets in melanoma.VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer
P2860
Q26749159-986B5D2B-29B1-450A-9BB9-9739ABA44591Q26825957-AA08AA2C-CD85-4ED9-8019-4DCA39574BEFQ26863442-FAB14A26-7F39-4674-BF8E-F6347E4EC254Q27853383-F1C182E5-CEA9-4296-AB2E-6E1A46FF3FA2Q28067131-6A01A2E6-2F22-4B19-B250-4875A3D466F8Q28068756-BD2390BE-E346-4AE0-BAFF-C2D45555458AQ28072503-114C3497-4903-4D89-9A09-C41D5A515A5AQ28076962-D4F60F80-F383-4894-9460-18DF6DB299AAQ28077444-A0D24AFC-16A4-4200-AADC-D70BBB62D432Q28477912-6EBA2301-F77A-4876-9C1D-9076101DE265Q28744461-171A4522-18C1-4DA0-946F-46C925060855Q30491493-EC4F8003-8C1E-43FA-B8A9-41DB6F58814BQ30656824-E2C6769E-F841-4CE5-B643-775C55609FCBQ30669159-FD78A711-613B-446E-8979-D8026D40F71FQ31152739-DA43302B-CABA-4EC2-8671-8A542BDE2C1EQ33598661-F1A65A19-5DB5-4B2B-84D4-1EDC662042BCQ33605227-6C70D623-E545-4CBF-976A-3186D255FE41Q33720291-A9E64DF0-7C26-409C-BCC0-528394A9FAF7Q33800254-1FA6DBC2-4935-4F3D-B770-C9BAB2B2D47CQ33891230-BE0A9E18-6E6A-4CAE-9F43-FBB428367565Q33916284-05BA1218-5ADA-4A78-A624-608CABB22D72Q33945493-302C6B21-AE9D-4C0B-A84A-0EEEDA6741CEQ34035977-74BFC07D-C393-4582-9950-10EDD830E72CQ34257303-03D9BC0E-CBB3-458A-A1EA-952B2457D26BQ34263230-1C8B15BA-E0B9-42D5-B7EF-B9885680D7B5Q34439798-67477605-2969-4EA3-87B5-38AE6918E395Q34441892-83F81C2A-4530-4CE2-9687-0A52F4FFE17EQ34451033-2C780F4B-E649-4A2D-B587-5C2564B8FFFDQ34473426-33C6E4C5-AC34-4EB5-9B36-BC2BD8907024Q34505037-35CF0109-3D15-4DDB-8E0C-3F70448165C2Q34515144-B2329635-EB20-4353-850D-BE184305F1CAQ34545399-E0EB526D-4489-4CC7-BD53-DA31EA4EFE3EQ34579646-EB218C65-FAF0-408B-A69E-F976985C4B1BQ34600387-91F261A3-C45E-40DE-A26B-D20FD8C5E78EQ34605643-7FB9D411-410C-40F3-9462-A5BFC51A95DEQ34619118-D4618AD0-4188-4162-A258-C7B248A12BF6Q34968578-468FA0A6-1E82-4521-8326-0C8338C9B578Q35053054-1C277029-B0D1-4E4B-92CD-5551FF77BB2AQ35053505-FDFFEE73-C680-4ACB-A93D-8404158D6CDEQ35112894-19864025-866B-4753-A6A7-243A505F7BBF
P2860
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Axl is an essential epithelial ...... tastasis and patient survival.
@ast
Axl is an essential epithelial ...... tastasis and patient survival.
@en
type
label
Axl is an essential epithelial ...... tastasis and patient survival.
@ast
Axl is an essential epithelial ...... tastasis and patient survival.
@en
prefLabel
Axl is an essential epithelial ...... tastasis and patient survival.
@ast
Axl is an essential epithelial ...... tastasis and patient survival.
@en
P2093
P2860
P50
P356
P1476
Axl is an essential epithelial ...... tastasis and patient survival.
@en
P2093
Carlotta Glackin
Christine Gjerdrum
Crina Tiron
David R Micklem
Emmet McCormack
Hallvard Haugen
Ingunn Stefansson
James B Lorens
Karin Collett
P2860
P304
P356
10.1073/PNAS.0909333107
P407
P577
2009-12-28T00:00:00Z